Unichem Laboratories Limited Pharmaceutical Export Profile — India (DGFT 2022–2026)

Name: Unichem Laboratories Limited Pharmaceutical Export Portfolio Dataset — 19 Products, $241.0M FOB USD, India (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Unichem Laboratories Limited — Pharmaceutical Exporter Profile (2026) | 19 Products, $241.0M Trade | TransData Nexus

Unichem Laboratories Limited

Indian Pharmaceutical Exporter · Cardiovascular Specialist · $241.0M Total Trade · DGFT Verified

Unichem Laboratories Limited is an Indian pharmaceutical exporter with a total trade value of $241.0M across 19 products in 9 therapeutic categories. Based on 5,363 verified export shipments from Indian Customs (DGFT) records, Unichem Laboratories Limited is the #1 Indian exporter in 4 products including Hydrochlorothiazide, Bisoprolol, Meloxicam. Top exports include Amlodipine ($34.5M), Iron ($32.2M), Allopurinol ($22.2M).

Unichem Laboratories Limited — Export Portfolio & Destination Treemap

Unichem Laboratories Limited pharmaceutical export portfolio — 19 products across 9 therapeutic categories. Source: Indian Customs (DGFT).

Who is Unichem Laboratories Limited? — Company Overview & Market Position

Unichem Laboratories Limited, established in 1944 by the late Mr. Amrut Mody, is a prominent Indian pharmaceutical company headquartered in Mumbai, Maharashtra. The company specializes in the manufacturing and marketing of pharmaceutical formulations across various therapeutic areas, including gastroenterology, cardiology, diabetology, psychiatry, neurology, anti-bacterials, anti-infectives, and pain management.

In August 1962, Unichem Laboratories Limited was incorporated as a public limited company under the Corporate Identification Number (CIN) L99999MH1962PLC012451. The company is listed on the Bombay Stock Exchange (BSE) under the ticker symbol 506690 and on the National Stock Exchange (NSE) under the ticker symbol UNICHEMLAB.

As of March 2025, Unichem Laboratories reported a revenue of ₹1,472.55 crore and a net worth of ₹2,294.63 crore. The company employs approximately 3,635 professionals. In 2023, Ipca Laboratories Limited acquired a 52.67% stake in Unichem Laboratories, further strengthening its position in the pharmaceutical industry.

What Does Unichem Laboratories Limited Export? — Product Portfolio Analysis

Top Products by Export Value

1Amlodipine$34.5M

Product Portfolio — Top 19 by Export Value

Unichem Laboratories Limited exports 19 pharmaceutical products across 9 therapeutic categories. Market leader (#1 exporter) in 4 products.

#	Product	Category	Export Value	Shipments	Market Share	Rank
1	Amlodipine	Cardiovascular	$34.5M	689	0.3%	2
2	Iron	Vitamins & Supplements	$32.2M	644	6.6%	2
3	Allopurinol	Lipid & Metabolism	$22.2M	444	4.5%	2
4	Hydrochlorothiazide	Diuretics	$21.3M	425	5.2%	1
5	Bisoprolol	Cardiovascular	$21.1M	422	25.0%	1
6	Meloxicam	Analgesics & Antipyretics	$18.4M	368	9.2%	1
7	Naproxen	Analgesics & Antipyretics	$13.8M	276	10.3%	2
8	Montelukast	Respiratory	$13.1M	262	7.8%	2
9	Metronidazole	Advanced Antibiotics	$11.7M	233	5.8%	2
10	Sodium	Nutritional Supplements	$10.9M	219	3.0%	6
11	Amoxicillin	Antibiotics	$10.3M	408	1.7%	8
12	Tramadol	Analgesics & Antipyretics	$10.3M	217	2.7%	3
13	Amiodarone	Cardiovascular	$5.2M	103	6.9%	1
14	Losartan	Cardiovascular	$5.1M	203	1.7%	15
15	Atenolol	Cardiovascular	$4.8M	266	11.9%	2
16	Clopidogrel	Cardiovascular	$3.3M	66	1.3%	12
17	Ampicillin	Antibiotics	$2.0M	55	1.4%	11
18	Secnidazole	Advanced Antibiotics	$459.3K	39	1.5%	7
19	Linezolid	Advanced Antibiotics	$416.3K	24	1.1%	13

Unichem Laboratories Limited exports 19 pharmaceutical products across 9 therapeutic categories with a total export value of $241.0M. The company is the #1 Indian exporter in 4 products: Hydrochlorothiazide, Bisoprolol, Meloxicam, Amiodarone. The top category is Cardiovascular (30.7% of portfolio), followed by Analgesics & Antipyretics (17.6%), reflecting a diversified portfolio where the top 5 products account for only 54.4% of total value.

Unichem Laboratories Limited — Corporate Profile & Information

Headquarters, ownership, manufacturing facilities, and key leadership

1Corporate Overview

2Manufacturing Facilities

Unichem Laboratories operates multiple manufacturing facilities across India, strategically located to serve both domestic and international markets. The company's formulation manufacturing plants are situated in Goa, Ghaziabad (Uttar Pradesh), and Baddi (Himachal Pradesh), while its Active Pharmaceutical Ingredient (API) manufacturing units are located in Roha (Maharashtra), Pithampur (Madhya Pradesh), and Kolhapur (Maharashtra).

These facilities are designed to meet the stringent quality standards required for global markets. Several of Unichem's plants have received approvals from international regulatory bodies, including the US FDA, UK MHRA, ANVISA (Brazil), COFEPRIS (Mexico), PMDA (Japan), TGA (Australia), and EDQM (Europe).

3Key Leadership

The leadership team at Unichem Laboratories is headed by Managing Director Pabitrakumar Kalipada Bhattacharyya, who oversees the company's strategic direction and operations. Sanjay Jain serves as the Chief Financial Officer, responsible for managing the company's financial strategies and performance.

Other key executives include Pradeep Bhandari, Head of Legal, Company Secretary, and Compliance Officer; Dr. Dhananjay Sathe, Chief Scientific and Compliance Officer; Prasad Joshi, Vice President of Human Resources and Employee Relations; Vinod Kumar Behl, Head of Projects and Investments; Jalesh Burye, Chief Quality and Compliance Officer; Utkarsh Patil, Chief Manufacturing Officer of Formulations; and Bhagwat S. Dhingra, Chief Executive of Domestic Pharma.

TransData Nexus Research · Government registries, company filings, regulatory databasesMar 2026

Where Does Unichem Laboratories Limited Export? — Destination Intelligence

Regulated market presence, emerging market penetration, and geographic strategy

1Regulated Markets

Unichem Laboratories has established a significant presence in regulated markets, including the United States, European Union, United Kingdom, Australia, and Japan. The company's formulation manufacturing facilities in Goa, Ghaziabad, and Baddi have received approvals from the US FDA, UK MHRA, and EDQM, facilitating access to these markets.

In the United States, Unichem has been proactive in obtaining Abbreviated New Drug Application (ANDA) approvals from the US FDA. For instance, in August 2020, the company received ANDA approval for Tolterodine Tartrate Tablets, and in July 2020, for Amiodarone Tablets. These approvals underscore Unichem's commitment to meeting the regulatory requirements of key international markets.

2Emerging Markets

Unichem Laboratories has expanded its footprint in emerging markets, including Africa, Latin America, and Southeast Asia. The company's manufacturing facilities have been accredited by international organizations such as the WHO, enabling access to these regions. Additionally, Unichem has established subsidiaries in Brazil and South Africa, further strengthening its presence in Latin America and Africa.

3Geographic Strategy

Unichem Laboratories Limited — Manufacturing & Regulatory Profile

FDA status, WHO-GMP certification, EU GMP compliance, and regulatory track record

1FDA Status

Unichem Laboratories has demonstrated a strong commitment to meeting the regulatory standards of the US market. The company's manufacturing facilities in Goa, Ghaziabad, and Pithampur have received approvals from the US FDA, indicating compliance with stringent quality and safety standards. Furthermore, Unichem has been proactive in obtaining ANDA approvals for its products, facilitating the introduction of generic formulations into the US market. For example, in August 2020, the company received ANDA approval for Tolterodine Tartrate Tablets.

2WHO & EU GMP

Unichem Laboratories' manufacturing facilities have been accredited by the World Health Organization (WHO) and the European Directorate for the Quality of Medicines (EDQM). These certifications affirm the company's adherence to international quality standards, enhancing its credibility and facilitating access to global markets.

3CDSCO & Indian Regulatory

In India, Unichem Laboratories holds manufacturing licenses from the Central Drugs Standard Control Organisation (CDSCO), ensuring compliance with national regulatory requirements. The company's facilities have also received approvals from state drug controllers, further validating their adherence to local standards. Additionally, Unichem has obtained export No Objection Certificates (NOCs), enabling the export of its products to various international markets.

Unichem Laboratories Limited — Competitive Positioning Among Indian Pharma Exporters

Market share comparison, key differentiators, and strategic analysis

1Competitive Landscape

In the pharmaceutical industry, Unichem Laboratories faces competition from both domestic and international companies. Key competitors include Sun Pharmaceutical Industries Ltd, Aurobindo Pharma Ltd, Divi's Laboratories Ltd, and Granules India Ltd. These companies operate in overlapping therapeutic categories and markets, contributing to a dynamic competitive environment.

2Key Differentiators

Unichem Laboratories distinguishes itself through its backward integration into Active Pharmaceutical Ingredient (API) manufacturing, adding value to customers in terms of quality and sustainability. The company's commitment to research and development, exemplified by its Centre of Excellence at Goa, enables the development of novel drug delivery systems and biosimilars.

3Strategic Position

Unichem Laboratories is strategically positioned as a global pharmaceutical company with a focus on generics, specialty products, and biosimilars. The company's robust research and development capabilities, coupled with its international manufacturing facilities, support its strategic direction and future growth prospects.

Buyer Due Diligence Brief — Evaluating Unichem Laboratories Limited as a Supplier

Track record assessment, certifications to verify, and pre-order checks

1Supplier Assessment

Unichem Laboratories has demonstrated a consistent track record in manufacturing and exporting pharmaceutical formulations. The company's export volume and consistency are evidenced by its total export value of $241.0 million USD and 5,363 shipments across 19 products in 9 therapeutic categories. Reliability indicators include approvals from multiple international regulatory bodies and a diversified product portfolio.

2Certifications to Verify

Importers should verify the following certifications to ensure product quality and compliance:

FDA Approval: Confirm the product's approval status through the US FDA's Orange Book.

WHO-GMP: Check the World Health Organization's list of prequalified manufacturers.

EU GMP: Review the European Medicines Agency's list of authorized manufacturers.

Frequently Asked Questions — Unichem Laboratories Limited

How many pharmaceutical products does Unichem Laboratories Limited export from India?

Unichem Laboratories Limited exports 19 pharmaceutical products across 9 therapeutic categories. The top exports are Amlodipine ($34.5M), Iron ($32.2M), Allopurinol ($22.2M), Hydrochlorothiazide ($21.3M), Bisoprolol ($21.1M). Total export value is $241.0M.

What is Unichem Laboratories Limited's total pharmaceutical export value?

Unichem Laboratories Limited's total pharmaceutical export value is $241.0M, based on 5,363 verified shipments recorded in Indian Customs (DGFT) data.

In which products is Unichem Laboratories Limited the #1 Indian exporter?

Unichem Laboratories Limited is the #1 Indian exporter in 4 products: Hydrochlorothiazide (5.2% market share), Bisoprolol (25.0% market share), Meloxicam (9.2% market share), Amiodarone (6.9% market share).

What therapeutic categories does Unichem Laboratories Limited cover?

Unichem Laboratories Limited exports across 9 therapeutic categories. The largest are Cardiovascular (30.7%, 6 products), Analgesics & Antipyretics (17.6%, 3 products), Vitamins & Supplements (13.4%, 1 products).

Get Full Unichem Laboratories Limited Export Intelligence

Access shipment-level details, pricing data, buyer connections, product breakdown, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify manufacturer licensing, GMP certification, and export registration with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports per product category. For current shipment-level data, contact TransData Nexus.